IceCure Medical (ICCM) Receivables - Net (2020 - 2026)

IceCure Medical (ICCM) has reported Receivables - Net for 7 consecutive years, with $413000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Receivables - Net rose 238.52% year-over-year to $413000.0 in Q2 2026; TTM through Jun 2026 was $413000.0, a 238.52% increase from a year earlier, with the FY2025 full-year figure at $331000.0, up 49.77% from the prior year.
• Receivables - Net was $413000.0 for Q2 2026 at IceCure Medical, up from $274000.0 in the prior quarter.
• Over five years, Receivables - Net peaked at $446000.0 in Q1 2022 and troughed at $78000.0 in Q4 2022.
• A 5-year average of $209055.6 and a median of $170500.0 in 2022 frame the typical range for Receivables - Net.
• Across the five-year window, Receivables - Net tumbled 82.89% in 2022 and jumped 238.52% in 2026, its largest moves.
• Over 5 years, Receivables - Net stood at $78000.0 in 2022, then jumped by 32.05% to $103000.0 in 2023, then surged by 114.56% to $221000.0 in 2024, then surged by 49.77% to $331000.0 in 2025, then increased by 24.77% to $413000.0 in 2026.
• The last three Receivables - Net figures came in at $413000.0 (Q2 2026), $274000.0 (Q1 2026), and $331000.0 (Q4 2025), per Business Quant data.